{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T12:20:41Z","timestamp":1790857241131,"version":"4.1.0"},"reference-count":109,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,9,19]],"date-time":"2025-09-19T00:00:00Z","timestamp":1758240000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001039","name":"Neurosurgical Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001039","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurochemistry International"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.neuint.2025.106054","type":"journal-article","created":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T21:21:40Z","timestamp":1758576100000},"page":"106054","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Further characterisation of the intrastriatal 6-OHDA Parkinson's disease model with non-motor symptom replication and widespread catecholamine dysfunction in male mice"],"prefix":"10.1016","volume":"190","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9282-7299","authenticated-orcid":false,"given":"Alisha","family":"Braun","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica","family":"Racz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanjay","family":"Garg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5793-6147","authenticated-orcid":false,"given":"Larisa","family":"Bobrovskaya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.neuint.2025.106054_bib1","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.expneurol.2007.10.012","article-title":"Characterization of the striatal 6-OHDA model of Parkinson's disease in wild type and \u03b1-synuclein-deleted mice","volume":"210","author":"Alvarez-Fischer","year":"2008","journal-title":"Exp. Neurol."},{"issue":"3","key":"10.1016\/j.neuint.2025.106054_bib2","doi-asserted-by":"crossref","first-page":"323","DOI":"10.31887\/DCNS.2004.6.3\/kanderson","article-title":"Behavioral disturbances in Parkinson's disease","volume":"6","author":"Anderson","year":"2004","journal-title":"Dialogues Clin. Neurosci."},{"issue":"1","key":"10.1016\/j.neuint.2025.106054_bib3","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.expneurol.2007.05.010","article-title":"Loss of enteric dopaminergic neurons and associated changes in colon motility in an MPTP mouse model of Parkinson's disease","volume":"207","author":"Anderson","year":"2007","journal-title":"Exp. Neurol."},{"issue":"7","key":"10.1016\/j.neuint.2025.106054_bib4","doi-asserted-by":"crossref","first-page":"3027","DOI":"10.1007\/s12035-020-01940-3","article-title":"Hesperidin ameliorates anxiety-depressive-like behavior in 6-OHDA model of Parkinson's disease by regulating striatal Cytokine and Neurotrophic factors levels and dopaminergic innervation loss in the striatum of mice","volume":"57","author":"Antunes","year":"2020","journal-title":"Mol. Neurobiol."},{"issue":"11","key":"10.1016\/j.neuint.2025.106054_bib5","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1016\/j.biopsych.2004.08.019","article-title":"Neurobiology of executive functions: catecholamine influences on prefrontal cortical functions","volume":"57","author":"Arnsten","year":"2005","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.neuint.2025.106054_bib6","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2019.00218","article-title":"Parkinson's disease and the environment","volume":"10","author":"Ball","year":"2019","journal-title":"Front. Neurol."},{"issue":"1","key":"10.1016\/j.neuint.2025.106054_bib7","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.parkreldis.2009.05.005","article-title":"[11C]-PK11195 PET: quantification of neuroinflammation and a monitor of anti-inflammatory treatment in Parkinson's disease?","volume":"16","author":"Bartels","year":"2010","journal-title":"Park. Relat. Disord."},{"issue":"5","key":"10.1016\/j.neuint.2025.106054_bib8","first-page":"4240","article-title":"Effect of intrastriatal 6-OHDA lesions on extrastriatal brain structures in the mouse","volume":"55","author":"Becker","year":"2018","journal-title":"Mol. Neurobiol."},{"issue":"1","key":"10.1016\/j.neuint.2025.106054_bib9","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1038\/s41531-017-0008-2","article-title":"Synaptic proteins in CSF relate to Parkinson's disease stage markers","volume":"3","author":"Bereczki","year":"2017","journal-title":"npj Parkinson's Dis."},{"key":"10.1016\/j.neuint.2025.106054_bib10","doi-asserted-by":"crossref","first-page":"27","DOI":"10.3389\/fnbeh.2014.00290","article-title":"A mouse model of non-motor symptoms in Parkinson's disease: focus on pharmacological interventions targeting affective dysfunctions","volume":"8","author":"Bonito-Oliva","year":"2014","journal-title":"Front. Behav. Neurosci."},{"issue":"1","key":"10.1016\/j.neuint.2025.106054_bib11","doi-asserted-by":"crossref","DOI":"10.1038\/srep26782","article-title":"Structural brain alterations associated with rapid eye movement sleep behavior disorder in Parkinson's disease","volume":"6","author":"Boucetta","year":"2016","journal-title":"Sci. Rep."},{"issue":"2","key":"10.1016\/j.neuint.2025.106054_bib12","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/S0197-4580(02)00065-9","article-title":"Staging of brain pathology related to sporadic Parkinson's disease","volume":"24","author":"Braak","year":"2003","journal-title":"Neurobiol. Aging"},{"issue":"1","key":"10.1016\/j.neuint.2025.106054_bib13","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.bbr.2009.11.020","article-title":"Striatal 6-OHDA lesion in mice: investigating early neurochemical changes underlying Parkinson's disease","volume":"208","author":"Branchi","year":"2010","journal-title":"Behav. Brain Res."},{"issue":"7","key":"10.1016\/j.neuint.2025.106054_bib14","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1002\/mds.26592","article-title":"Hypothalamic volume loss is associated with reduced melatonin output in Parkinson's disease","volume":"31","author":"Breen","year":"2016","journal-title":"Mov. Disord."},{"issue":"s2","key":"10.1016\/j.neuint.2025.106054_bib15","doi-asserted-by":"crossref","first-page":"S331","DOI":"10.3233\/JPD-191729","article-title":"Inflammatory bowel diseases and Parkinson's disease","volume":"9","author":"Brudek","year":"2019","journal-title":"J. Parkinsons Dis."},{"issue":"7","key":"10.1016\/j.neuint.2025.106054_bib16","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1002\/mds.10444","article-title":"Parkinson's disease is associated with hippocampal atrophy","volume":"18","author":"Camicioli","year":"2003","journal-title":"Mov. Disord."},{"key":"10.1016\/j.neuint.2025.106054_bib17","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1016\/j.nicl.2017.03.011","article-title":"Axonal damage and loss of connectivity in nigrostriatal and mesolimbic dopamine pathways in early Parkinson's disease","volume":"14","author":"Caminiti","year":"2017","journal-title":"Neuroimage: Clinical"},{"key":"10.1016\/j.neuint.2025.106054_bib18","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2024.1351718","article-title":"Aqueous extract of Swietenia macrophylla leaf exerts an anti-inflammatory effect in a murine model of Parkinson's disease induced by 6-OHDA","volume":"18","author":"Cardoso","year":"2024","journal-title":"Front. Neurosci."},{"issue":"2","key":"10.1016\/j.neuint.2025.106054_bib19","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/0306-4522(92)90099-N","article-title":"Mesostriatal and mesolimbic dopamine uptake binding sites are reduced in Parkinson's disease and progressive supranuclear palsy: a quantitative autoradiographic study using [3H]mazindol","volume":"49","author":"Chinaglia","year":"1992","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuint.2025.106054_bib20","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.neuropharm.2013.11.014","article-title":"Selegiline normalizes, while l-DOPA sustains the increased number of dopamine neurons in the olfactory bulb in a 6-OHDA mouse model of Parkinson's disease","volume":"79","author":"Chiu","year":"2014","journal-title":"Neuropharmacology"},{"issue":"3","key":"10.1016\/j.neuint.2025.106054_bib21","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1038\/s41386-018-0246-y","article-title":"Dopamine is a double-edged sword: dopaminergic modulation enhances memory retrieval performance but impairs metacognition","volume":"44","author":"Clos","year":"2019","journal-title":"Neuropsychopharmacology"},{"issue":"1","key":"10.1016\/j.neuint.2025.106054_bib22","doi-asserted-by":"crossref","first-page":"3721","DOI":"10.1038\/s41598-024-54066-0","article-title":"Characterization of graded 6-Hydroxydopamine unilateral lesion in medial forebrain bundle of mice","volume":"14","author":"Cui","year":"2024","journal-title":"Sci. Rep."},{"issue":"6","key":"10.1016\/j.neuint.2025.106054_bib23","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1016\/S0896-6273(03)00568-3","article-title":"Parkinson's disease: mechanisms and models","volume":"39","author":"Dauer","year":"2003","journal-title":"Neuron"},{"issue":"2","key":"10.1016\/j.neuint.2025.106054_bib24","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1016\/j.neuroimage.2004.11.023","article-title":"Executive dysfunction in Parkinson's disease is associated with altered pallidal\u2013frontal processing","volume":"25","author":"Dirnberger","year":"2005","journal-title":"Neuroimage"},{"issue":"6","key":"10.1016\/j.neuint.2025.106054_bib25","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1038\/nrneurol.2012.80","article-title":"Olfactory dysfunction in Parkinson disease","volume":"8","author":"Doty","year":"2012","journal-title":"Nat. Rev. Neurol."},{"issue":"8","key":"10.1016\/j.neuint.2025.106054_bib26","doi-asserted-by":"crossref","DOI":"10.1007\/s11011-021-00851-z","article-title":"The effect of URB597, exercise or their combination on the performance of 6-OHDA mouse model of Parkinson disease in the elevated plus maze, tail suspension test and step-down task","volume":"36","author":"Ebrahimi-Ghiri","year":"2021","journal-title":"Metab. Brain Dis."},{"issue":"3","key":"10.1016\/j.neuint.2025.106054_bib27","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1007\/s00441-018-2800-7","article-title":"Dopaminergic innervation and modulation of hippocampal networks","volume":"373","author":"Edelmann","year":"2018","journal-title":"Cell Tissue Res."},{"issue":"1","key":"10.1016\/j.neuint.2025.106054_bib28","doi-asserted-by":"crossref","DOI":"10.1038\/srep30269","article-title":"Restoration of intestinal function in an MPTP model of Parkinson's Disease","volume":"6","author":"Ellett","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.neuint.2025.106054_bib29","article-title":"'Cognition deficits in Parkinson's disease: mechanisms and treatment'","volume":"2020","author":"Fang","year":"2020","journal-title":"Parkinsons Dis."},{"issue":"6","key":"10.1016\/j.neuint.2025.106054_bib30","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/S1474-4422(15)00007-1","article-title":"Gastrointestinal dysfunction in Parkinson's disease","volume":"14","author":"Fasano","year":"2015","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.neuint.2025.106054_bib31","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.freeradbiomed.2013.05.027","article-title":"SOD2 in mitochondrial dysfunction and neurodegeneration","volume":"62","author":"Flynn","year":"2013","journal-title":"Free Radic. Biol. Med."},{"issue":"1","key":"10.1016\/j.neuint.2025.106054_bib32","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1038\/s41386-021-01132-0","article-title":"The role of prefrontal cortex in cognitive control and executive function","volume":"47","author":"Friedman","year":"2022","journal-title":"Neuropsychopharmacology"},{"issue":"2","key":"10.1016\/j.neuint.2025.106054_bib33","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/S0959-4388(96)80076-6","article-title":"The amygdala and emotion","volume":"6","author":"Gallagher","year":"1996","journal-title":"Curr. Opin. Neurobiol."},{"key":"10.1016\/j.neuint.2025.106054_bib34","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.neuroscience.2013.09.042","article-title":"Neuroprotective effects of swimming training in a mouse model of Parkinson's disease induced by 6-hydroxydopamine","volume":"256","author":"Goes","year":"2014","journal-title":"Neuroscience"},{"issue":"11","key":"10.1016\/j.neuint.2025.106054_bib35","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1016\/S1474-4422(17)30299-5","article-title":"Global, regional, and national burden of neurological disorders during 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015","volume":"16","author":"Group","year":"2017","journal-title":"Lancet Neurol."},{"issue":"11","key":"10.1016\/j.neuint.2025.106054_bib36","doi-asserted-by":"crossref","first-page":"2431","DOI":"10.1093\/brain\/awf251","article-title":"Clinical correlates of selective pathology in the amygdala of patients with Parkinson's disease","volume":"125","author":"Harding","year":"2002","journal-title":"Brain"},{"issue":"2","key":"10.1016\/j.neuint.2025.106054_bib37","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0017461","article-title":"Neurobehavioral mechanisms of temporal processing deficits in Parkinson's disease","volume":"6","author":"Harrington","year":"2011","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.neuint.2025.106054_bib38","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/s10020-021-00301-7","article-title":"Clinical implications for dopaminergic and functional neuroimage research in cognitive symptoms of Parkinson's disease","volume":"27","author":"Hirano","year":"2021","journal-title":"Mol. Med."},{"issue":"3","key":"10.1016\/j.neuint.2025.106054_bib39","doi-asserted-by":"crossref","DOI":"10.1016\/j.phyplu.2022.100297","article-title":"Treatment with bark extracts of Voacanga africana attenuates motor coordination deficit, depressive-like behavior and microglial reaction, in a mouse model of early Parkinson's disease","volume":"2","author":"Houndjo","year":"2022","journal-title":"Phytomed. Plus"},{"key":"10.1016\/j.neuint.2025.106054_bib40","doi-asserted-by":"crossref","DOI":"10.1016\/j.neulet.2023.137608","article-title":"Mangiferin alleviates 6-OHDA-induced Parkinson's disease by inhibiting AKR1C3 to activate Wnt signaling pathway","volume":"821","author":"Huang","year":"2024","journal-title":"Neurosci. Lett."},{"issue":"6","key":"10.1016\/j.neuint.2025.106054_bib41","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1002\/mds.10713","article-title":"A 100% increase of dopaminergic cells in the olfactory bulb may explain hyposmia in Parkinson's disease","volume":"19","author":"Huisman","year":"2004","journal-title":"Mov. Disord."},{"issue":"9","key":"10.1016\/j.neuint.2025.106054_bib42","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1007\/s00415-008-0885-8","article-title":"Hippocampal head atrophy predominance in Parkinson's disease with hallucinations and with dementia","volume":"255","author":"Ibarretxe-Bilbao","year":"2008","journal-title":"J. Neurol."},{"issue":"3","key":"10.1016\/j.neuint.2025.106054_bib43","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1093\/brain\/awq012","article-title":"Dopaminergic modulation of striato-frontal connectivity during motor timing in Parkinson's disease","volume":"133","author":"Jahanshahi","year":"2010","journal-title":"Brain"},{"issue":"5","key":"10.1016\/j.neuint.2025.106054_bib44","doi-asserted-by":"crossref","DOI":"10.1212\/WNL.34.5.672","article-title":"Biochemistry of the hypothalamus in Parkinson's disease","volume":"34","author":"Javoy-Agid","year":"1984","journal-title":"Neurology"},{"issue":"S3","key":"10.1016\/j.neuint.2025.106054_bib45","doi-asserted-by":"crossref","first-page":"S26","DOI":"10.1002\/ana.10483","article-title":"Oxidative stress in Parkinson's disease","volume":"53","author":"Jenner","year":"2003","journal-title":"Ann. Neurol."},{"issue":"2","key":"10.1016\/j.neuint.2025.106054_bib46","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.parkreldis.2008.03.005","article-title":"Impaired cognitive performance in Parkinson's disease is related to caudate dopaminergic hypofunction and hippocampal atrophy","volume":"15","author":"Jokinen","year":"2009","journal-title":"Park. Relat. Disord."},{"issue":"7","key":"10.1016\/j.neuint.2025.106054_bib47","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1212\/WNL.54.7.1482","article-title":"Extrastriatal dopamine D2 and D3 receptors in early and advanced Parkinson's disease","volume":"54","author":"Kaasinen","year":"2000","journal-title":"Neurology"},{"issue":"4","key":"10.1016\/j.neuint.2025.106054_bib48","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1038\/s41419-024-06670-1","article-title":"Protective effect of increased O-GlcNAc cycling against 6-OHDA induced Parkinson's disease pathology","volume":"15","author":"Kim","year":"2024","journal-title":"Cell Death Dis."},{"issue":"1","key":"10.1016\/j.neuint.2025.106054_bib49","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1186\/s40478-020-01083-5","article-title":"Neuroinflammation and protein pathology in Parkinson's disease dementia","volume":"8","author":"Kouli","year":"2020","journal-title":"Acta Neuropathol.Commun."},{"issue":"2","key":"10.1016\/j.neuint.2025.106054_bib50","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1002\/ana.410030207","article-title":"The hypothalamus in Parkinson disease","volume":"3","author":"Langston","year":"1978","journal-title":"Ann. Neurol."},{"issue":"14","key":"10.1016\/j.neuint.2025.106054_bib51","doi-asserted-by":"crossref","DOI":"10.3390\/molecules28145527","article-title":"Artemisinin confers neuroprotection against 6-OHDA-induced neuronal injury in vitro and in vivo through activation of the ERK1\/2 pathway","volume":"28","author":"Li","year":"2023","journal-title":"Molecules"},{"issue":"8","key":"10.1016\/j.neuint.2025.106054_bib52","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines10081776","article-title":"CB2 agonist GW842166x protected against 6-OHDA-induced anxiogenic- and depressive-related behaviors in mice","volume":"10","author":"Liu","year":"2022","journal-title":"Biomedicines"},{"key":"10.1016\/j.neuint.2025.106054_bib53","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.parkreldis.2020.02.001","article-title":"Non-motor symptoms and striatal dopamine transporter binding in early Parkinson's disease","volume":"72","author":"Liu","year":"2020","journal-title":"Park. Relat. Disord."},{"issue":"1","key":"10.1016\/j.neuint.2025.106054_bib54","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1186\/s13578-023-01049-9","article-title":"Amelioration of olfactory dysfunction in a mouse model of Parkinson's disease via enhancing GABAergic signaling","volume":"13","author":"Liu","year":"2023","journal-title":"Cell Biosci."},{"issue":"1","key":"10.1016\/j.neuint.2025.106054_bib55","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.celrep.2019.03.012","article-title":"Dopamine modulation of prefrontal cortex activity is manifold and operates at multiple temporal and spatial scales","volume":"27","author":"Lohani","year":"2019","journal-title":"Cell Rep."},{"issue":"3","key":"10.1016\/j.neuint.2025.106054_bib56","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1016\/j.ajpath.2015.09.023","article-title":"Dopaminergic neurons and brain reward pathways: from neurogenesis to circuit assembly","volume":"186","author":"Luo","year":"2016","journal-title":"Am. J. Pathol."},{"issue":"4","key":"10.1016\/j.neuint.2025.106054_bib57","doi-asserted-by":"crossref","first-page":"e88","DOI":"10.1038\/tp.2017.58","article-title":"The histamine H3 receptor antagonist thioperamide rescues circadian rhythm and memory function in experimental parkinsonism","volume":"7","author":"Masini","year":"2017","journal-title":"Transl. Psychiatry"},{"issue":"8","key":"10.1016\/j.neuint.2025.106054_bib58","doi-asserted-by":"crossref","DOI":"10.1212\/WNL.38.8.1285","article-title":"Reactive microglia are positive for HLA\u2010DR in the substantia nigra of Parkinson's and Alzheimer's disease brains","volume":"38","author":"McGeer","year":"1988","journal-title":"Neurology"},{"issue":"7","key":"10.1016\/j.neuint.2025.106054_bib59","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.tins.2017.05.005","article-title":"Two sources of dopamine for the hippocampus","volume":"40","author":"McNamara","year":"2017","journal-title":"Trends Neurosci."},{"issue":"1","key":"10.1016\/j.neuint.2025.106054_bib60","doi-asserted-by":"crossref","first-page":"7934","DOI":"10.1038\/s41598-021-86917-5","article-title":"The association of enteric neuropathy with gut phenotypes in acute and progressive models of Parkinson's disease","volume":"11","author":"McQuade","year":"2021","journal-title":"Sci. Rep."},{"issue":"16","key":"10.1016\/j.neuint.2025.106054_bib61","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2024.e35948","article-title":"Dopamine D2 receptor activation counteracts olfactory dysfunction and related cellular abnormalities in experimental parkinsonism","volume":"10","author":"Medeiros","year":"2024","journal-title":"Heliyon"},{"issue":"21","key":"10.1016\/j.neuint.2025.106054_bib63","doi-asserted-by":"crossref","DOI":"10.3390\/ijms222111530","article-title":"Unilateral intrastriatal 6-hydroxydopamine lesion in mice: a closer look into non-motor phenotype and glial response","volume":"22","author":"Mendes-Pinheiro","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"2","key":"10.1016\/j.neuint.2025.106054_bib64","doi-asserted-by":"crossref","DOI":"10.3390\/diagnostics11020207","article-title":"A review of selected IBD biomarkers: from animal models to bedside","volume":"11","author":"Mizoguchi","year":"2021","journal-title":"Diagnostics"},{"issue":"10423","key":"10.1016\/j.neuint.2025.106054_bib65","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/S0140-6736(23)01478-2","article-title":"The pathogenesis of Parkinson's disease","volume":"403","author":"Morris","year":"2024","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.neuint.2025.106054_bib66","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1007\/s00401-011-0830-2","article-title":"Increased dopaminergic cells and protein aggregates in the olfactory bulb of patients with neurodegenerative disorders","volume":"122","author":"Mundi\u00f1ano","year":"2011","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.neuint.2025.106054_bib67","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.neuroscience.2019.02.008","article-title":"SNAP-25 in major psychiatric disorders: a review","volume":"420","author":"Najera","year":"2019","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuint.2025.106054_bib68","doi-asserted-by":"crossref","DOI":"10.3389\/fncel.2022.826193","article-title":"Evidence that substantia nigra pars compacta dopaminergic neurons are selectively vulnerable to oxidative stress because they are highly metabolically active","volume":"16","author":"Ni","year":"2022","journal-title":"Front. Cell. Neurosci."},{"issue":"1","key":"10.1016\/j.neuint.2025.106054_bib69","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1002\/mds.21813","article-title":"Nonmotor symptoms as presenting complaints in Parkinson's disease: a clinicopathological study","volume":"23","author":"O'Sullivan","year":"2008","journal-title":"Mov. Disord."},{"issue":"S2","key":"10.1016\/j.neuint.2025.106054_bib70","doi-asserted-by":"crossref","first-page":"S30","DOI":"10.1002\/ana.21481","article-title":"The basal ganglia in Parkinson's disease: current concepts and unexplained observations","volume":"64","author":"Obeso","year":"2008","journal-title":"Ann. Neurol."},{"issue":"14","key":"10.1016\/j.neuint.2025.106054_bib71","doi-asserted-by":"crossref","DOI":"10.3390\/ijms25147993","article-title":"Mouse model of Parkinson's disease with bilateral dorsal striatum lesion with 6-hydroxydopamine exhibits cognitive apathy-like behavior","volume":"25","author":"Okitsu","year":"2024","journal-title":"Int. J. Mol. Sci."},{"issue":"3","key":"10.1016\/j.neuint.2025.106054_bib72","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.tics.2018.12.006","article-title":"Dopamine and cognitive control in prefrontal cortex","volume":"23","author":"Ott","year":"2019","journal-title":"Trends Cognit. Sci."},{"issue":"5","key":"10.1016\/j.neuint.2025.106054_bib73","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1002\/1531-8249(199905)45:5<601::AID-ANA8>3.0.CO;2-0","article-title":"Alterations in binding site density of dopamine transporter in the striatum, orbitofrontal cortex, and amygdala in early Parkinson's disease: compartment analysis for \u03b2-CFT binding with positron emission tomography","volume":"45","author":"Ouchi","year":"1999","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.neuint.2025.106054_bib74","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2024.112715","article-title":"Escitalopram moderately outperforms citalopram towards anti-neuroinflammation and neuroprotection in 6-hydroxydopamine-induced mouse model of Parkinson's disease","volume":"139","author":"Ovlyakulov","year":"2024","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.neuint.2025.106054_bib75","doi-asserted-by":"crossref","first-page":"S119","DOI":"10.1016\/j.parkreldis.2015.09.004","article-title":"Non-motor symptoms in Parkinson's disease","volume":"22","author":"Pfeiffer","year":"2016","journal-title":"Park. Relat. Disord."},{"issue":"5321","key":"10.1016\/j.neuint.2025.106054_bib76","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1126\/science.276.5321.2045","article-title":"Mutation in the \u03b1-synuclein gene identified in families with Parkinson's disease","volume":"276","author":"Polymeropoulos","year":"1997","journal-title":"Science"},{"issue":"2","key":"10.1016\/j.neuint.2025.106054_bib77","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1007\/s12640-009-9087-0","article-title":"Single intranasal administration of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in C57BL\/6 mice models early preclinical phase of Parkinson's disease","volume":"17","author":"Prediger","year":"2010","journal-title":"Neurotox. Res."},{"issue":"17","key":"10.1016\/j.neuint.2025.106054_bib78","doi-asserted-by":"crossref","first-page":"R764","DOI":"10.1016\/j.cub.2013.05.041","article-title":"Interplay of hippocampus and prefrontal cortex in memory","volume":"23","author":"Preston","year":"2013","journal-title":"Curr. Biol."},{"key":"10.1016\/j.neuint.2025.106054_bib79","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.neuroscience.2014.09.026","article-title":"Prefrontal dopamine in associative learning and memory","volume":"282","author":"Puig","year":"2014","journal-title":"Neuroscience"},{"issue":"12","key":"10.1016\/j.neuint.2025.106054_bib81","doi-asserted-by":"crossref","first-page":"3502","DOI":"10.1007\/s10620-019-05693-5","article-title":"Impairment of Nrf2- and nitrergic-mediated gastrointestinal motility in an MPTP mouse model of Parkinson's disease","volume":"64","author":"Sampath","year":"2019","journal-title":"Dig. Dis. Sci."},{"key":"10.1016\/j.neuint.2025.106054_bib82","doi-asserted-by":"crossref","DOI":"10.1038\/s41531-025-00872-w","article-title":"Mapping of catecholaminergic denervation, neurodegeneration, and inflammation in 6-OHDA-treated Parkinson\u2019s disease mice","author":"Santoro","year":"2025","journal-title":"npj Parkinson\u2019s Disease, vol. 11, no. 1, 2025\/02\/11, p. 28."},{"key":"10.1016\/j.neuint.2025.106054_bib83","series-title":"Encyclopedia of Neuroscience","first-page":"2977","article-title":"Olfactory bulb","author":"Sasso\u00e8-Pognetto","year":"2009"},{"issue":"8","key":"10.1016\/j.neuint.2025.106054_bib84","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2023.e18473","article-title":"Abscisic acid ameliorates motor disabilities in 6-OHDA-induced mice model of Parkinson's disease","volume":"9","author":"Shabani","year":"2023","journal-title":"Heliyon"},{"issue":"1","key":"10.1016\/j.neuint.2025.106054_bib85","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/0006-8993(94)91761-2","article-title":"Noradrenaline, dopamine and serotonin levels and metabolism in the human hypothalamus: observations in Parkinson's disease and normal subjects","volume":"639","author":"Shannak","year":"1994","journal-title":"Brain Res."},{"issue":"3","key":"10.1016\/j.neuint.2025.106054_bib86","doi-asserted-by":"crossref","first-page":"568","DOI":"10.3390\/ijms20030568","article-title":"Deciduous DPSCs ameliorate MPTP-mediated neurotoxicity, sensorimotor coordination and olfactory function in parkinsonian mice","volume":"20","author":"Simon","year":"2019","journal-title":"Int. J. Mol. Sci."},{"issue":"8979","key":"10.1016\/j.neuint.2025.106054_bib87","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1016\/S0140-6736(95)92707-7","article-title":"Dopaminergic defect of enteric nervous system in Parkinson's disease patients with chronic constipation","volume":"346","author":"Singaram","year":"1995","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.neuint.2025.106054_bib88","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-023-46576-0","article-title":"Behavioral, neural and ultrastructural alterations in a graded-dose 6-OHDA mouse model of early-stage Parkinson's disease","volume":"13","author":"Sl\u00e9zia","year":"2023","journal-title":"Sci. Rep."},{"key":"10.1016\/j.neuint.2025.106054_bib89","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuint.2021.105215","article-title":"Role of toll-like receptor 4 and sex in 6-hydroxydopamine\u2013induced behavioral impairments and neurodegeneration in mice","volume":"151","author":"Somensi","year":"2021","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.neuint.2025.106054_bib90","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2019.00702","article-title":"Chemogenetic modulation of orexin neurons reverses changes in anxiety and locomotor activity in the A53T mouse model of Parkinson's disease","volume":"13","author":"Stanojlovic","year":"2019","journal-title":"Front. Neurosci."},{"issue":"50","key":"10.1016\/j.neuint.2025.106054_bib91","doi-asserted-by":"crossref","first-page":"8733","DOI":"10.1523\/JNEUROSCI.1037-23.2023","article-title":"Accentuated paralimbic and reduced mesolimbic D2\/3-impulsivity associations in Parkinson's disease","volume":"43","author":"Stark","year":"2023","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuint.2025.106054_bib92","doi-asserted-by":"crossref","DOI":"10.3389\/fnbeh.2022.982218","article-title":"Longitudinal assessment of motor function following the unilateral intrastriatal 6-hydroxydopamine lesion model in mice","volume":"16","author":"Sun","year":"2022","journal-title":"Front. Behav. Neurosci."},{"issue":"5","key":"10.1016\/j.neuint.2025.106054_bib93","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1212\/01.WNL.0000153070.82309.D4","article-title":"Temporal lobe atrophy on MRI in Parkinson disease with dementia","volume":"64","author":"Tam","year":"2005","journal-title":"Neurology"},{"key":"10.1016\/j.neuint.2025.106054_bib94","doi-asserted-by":"crossref","first-page":"S74","DOI":"10.1016\/S1353-8020(11)70024-4","article-title":"Mood disorders in Parkinson's disease","volume":"18","author":"Tan","year":"2012","journal-title":"Park. Relat. Disord."},{"issue":"1","key":"10.1016\/j.neuint.2025.106054_bib95","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.expneurol.2007.07.004","article-title":"Neuroinflammatory mechanisms in Parkinson's disease: potential environmental triggers, pathways, and targets for early therapeutic intervention","volume":"208","author":"Tansey","year":"2007","journal-title":"Exp. Neurol."},{"issue":"20","key":"10.1016\/j.neuint.2025.106054_bib96","doi-asserted-by":"crossref","first-page":"9099","DOI":"10.1523\/JNEUROSCI.22-20-09099.2002","article-title":"Dopamine modulates the response of the human amygdala: a study in Parkinson's disease","volume":"22","author":"Tessitore","year":"2002","journal-title":"J. Neurosci. : the official journal of the Society for Neuroscience"},{"issue":"4","key":"10.1016\/j.neuint.2025.106054_bib97","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1093\/brain\/awq032","article-title":"Non-motor dopamine withdrawal syndrome after surgery for Parkinson's disease: predictors and underlying mesolimbic denervation","volume":"133","author":"Thobois","year":"2010","journal-title":"Brain"},{"key":"10.1016\/j.neuint.2025.106054_bib98","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.brainresbull.2022.06.013","article-title":"Enteric glial cell reactivity in colonic layers and mucosal modulation in a mouse model of Parkinson's disease induced by 6-hydroxydopamine","volume":"187","author":"Thomasi","year":"2022","journal-title":"Brain Res. Bull."},{"issue":"3","key":"10.1016\/j.neuint.2025.106054_bib99","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1016\/j.neuroscience.2008.02.033","article-title":"Alteration of dopaminergic markers in gastrointestinal tract of different rodent models of Parkinson's disease","volume":"153","author":"Tian","year":"2008","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuint.2025.106054_bib100","doi-asserted-by":"crossref","DOI":"10.3389\/fnbeh.2021.667244","article-title":"The importance of ventral hippocampal dopamine and norepinephrine in recognition memory","volume":"15","author":"Titulaer","year":"2021","journal-title":"Front. Behav. Neurosci."},{"issue":"2","key":"10.1016\/j.neuint.2025.106054_bib101","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1007\/BF02251479","article-title":"Tyrosine hydroxylase-like (TH) immunoreactivity in Parkinson's disease and Alzheimer's disease","volume":"4","author":"Torack","year":"1992","journal-title":"J. Neural Transm. Parkinson\u2019s Dis. Dementia Sect."},{"issue":"12","key":"10.1016\/j.neuint.2025.106054_bib102","doi-asserted-by":"crossref","DOI":"10.1097\/WNR.0000000000000218","article-title":"Unilateral olfactory deficit in a hemiparkinson's disease mouse model","volume":"25","author":"Valle-Leija","year":"2014","journal-title":"Neuroreport"},{"issue":"3","key":"10.1016\/j.neuint.2025.106054_bib103","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.3233\/JPD-202465","article-title":"The human Hippocampus in Parkinson's disease: an integrative stereological and proteomic study","volume":"11","author":"Villar-Conde","year":"2021","journal-title":"J. Parkinsons Dis."},{"issue":"1","key":"10.1016\/j.neuint.2025.106054_bib104","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1186\/s40001-023-01360-8","article-title":"SNAP25 is a potential target for early stage Alzheimer's disease and Parkinson's disease","volume":"28","author":"Wang","year":"2023","journal-title":"Eur. J. Med. Res."},{"key":"10.1016\/j.neuint.2025.106054_bib105","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.neuro.2019.11.009","article-title":"Twice subacute MPTP administrations induced time-dependent dopaminergic neurodegeneration and inflammation in midbrain and ileum, as well as gut microbiota disorders in PD mice","volume":"76","author":"Xie","year":"2020","journal-title":"Neurotoxicology"},{"key":"10.1016\/j.neuint.2025.106054_bib106","doi-asserted-by":"crossref","DOI":"10.1016\/j.exger.2019.110743","article-title":"The neuroprotective effect of schisandrol A on 6-OHDA-induced PD mice may be related to PI3K\/AKT and IKK\/I\u03baB\u03b1\/NF-\u03baB pathway","volume":"128","author":"Yan","year":"2019","journal-title":"Exp. Gerontol."},{"key":"10.1016\/j.neuint.2025.106054_bib107","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.neuro.2019.02.008","article-title":"Nicotine improved the olfactory impairment in MPTP-induced mouse model of Parkinson's disease","volume":"73","author":"Yang","year":"2019","journal-title":"Neurotoxicology"},{"issue":"2","key":"10.1016\/j.neuint.2025.106054_bib108","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/j.neuroscience.2004.09.054","article-title":"The amygdala of patients with Parkinson's disease is silent in response to fearful facial expressions","volume":"131","author":"Yoshimura","year":"2005","journal-title":"Neuroscience"},{"issue":"12","key":"10.1016\/j.neuint.2025.106054_bib109","doi-asserted-by":"crossref","DOI":"10.3390\/cells10123548","article-title":"The neuroprotective effects of the CB2 agonist GW842166x in the 6-OHDA mouse model of Parkinson's disease","volume":"10","author":"Yu","year":"2021","journal-title":"Cells"},{"issue":"1","key":"10.1016\/j.neuint.2025.106054_bib110","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1038\/s41598-018-36538-2","article-title":"Partial depletion of dopaminergic neurons in the substantia nigra impairs olfaction and alters neural activity in the olfactory bulb","volume":"9","author":"Zhang","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.neuint.2025.106054_bib111","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2024.106472","article-title":"Microstructural alterations of the hypothalamus in Parkinson's disease and probable REM sleep behavior disorder","volume":"194","author":"Zhou","year":"2024","journal-title":"Neurobiol. Dis."}],"container-title":["Neurochemistry International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0197018625001275?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0197018625001275?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T13:44:14Z","timestamp":1780407854000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0197018625001275"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":109,"alternative-id":["S0197018625001275"],"URL":"https:\/\/doi.org\/10.1016\/j.neuint.2025.106054","relation":{},"ISSN":["0197-0186"],"issn-type":[{"value":"0197-0186","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Further characterisation of the intrastriatal 6-OHDA Parkinson's disease model with non-motor symptom replication and widespread catecholamine dysfunction in male mice","name":"articletitle","label":"Article Title"},{"value":"Neurochemistry International","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuint.2025.106054","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"106054"}}